In univariate analysis, acute post-IVT endophthalmitis was more likely to occur in younger patients, with corticosteroid IVTs, with non-prefilled anti-VEGF syringes (vs. prefilled ranibizumab), and at the beginning of the study period, with a decreasing IRR over the years (Figure 4). Here, VEGFA is linked to endophthalmitis.